{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:48:45Z","timestamp":1757623725297,"version":"3.44.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.rcsop.2022.100190","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T13:40:54Z","timestamp":1665409254000},"page":"100190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Rationalising Antipsychotic Prescribing in Dementia (RAPID) complex intervention: A mixed-methods feasibility intervention study"],"prefix":"10.1016","volume":"8","author":[{"given":"Kieran A.","family":"Walsh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"O'Riordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"McSharry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Browne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Irving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eimir","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Timmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2022.100190_bb0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.euroneuro.2017.01.002","article-title":"Benefits and harms of atypical antipsychotics for agitation in adults with dementia","volume":"27","author":"Farlow","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.rcsop.2022.100190_bb0010","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/0706743716673321","article-title":"Antipsychotic use in dementia:is there a problem and are there solutions?","volume":"62","author":"Kirkham","year":"2017","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.rcsop.2022.100190_bb0015","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jamapsychiatry.2014.3018","article-title":"Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm","volume":"72","author":"Maust","year":"2015","journal-title":"JAMA Psychiat"},{"key":"10.1016\/j.rcsop.2022.100190_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/ADR-170042","article-title":"Increased all-cause mortality by antipsychotic drugs: updated review and meta-analysis in dementia and general mental health care","volume":"2","author":"Ralph","year":"2018","journal-title":"J Alzheimer\u2019s Dis Rep"},{"key":"10.1016\/j.rcsop.2022.100190_bb0025","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1017\/S1041610216001307","article-title":"Patterns of psychotropic prescribing and polypharmacy in older hospitalized patients in Ireland: the influence of dementia on prescribing","volume":"28","author":"Walsh","year":"2016","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.rcsop.2022.100190_bb0030","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1017\/S1041610216001150","article-title":"Psychotropic drug prescriptions in Western European nursing homes","volume":"28","author":"Janus","year":"2016","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.rcsop.2022.100190_bb0035","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jamda.2014.06.012","article-title":"Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: a systematic review","volume":"15","author":"Thompson Coon","year":"2014","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"10.1016\/j.rcsop.2022.100190_bb0040","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/jamainternmed.2021.0224","article-title":"Assessment of psychotropic drug prescribing among nursing home residents in Ontario, Canada, during the COVID-19 pandemic","volume":"181","author":"Stall","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.rcsop.2022.100190_bb0045","first-page":"1589","article-title":"Only 10% of the psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate. The PROPER I-study International psychogeriatrics","volume":"28","author":"van der Spek","year":"2016"},{"key":"10.1016\/j.rcsop.2022.100190_bb0050","first-page":"1","article-title":"General practitioners\u2019 knowledge, attitudes and experiences of managing behavioural and psychological symptoms of dementia: a mixed methods systematic review","author":"Jennings","year":"2018","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.rcsop.2022.100190_bb0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40266-018-0527-5","article-title":"Relationship between organizational culture and the use of psychotropic medicines in nursing homes: a systematic integrative review","volume":"35","author":"Sawan","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.rcsop.2022.100190_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2017.06.032","article-title":"Influences on decision-making regarding antipsychotic prescribing in nursing home residents with dementia: a systematic review and synthesis of qualitative evidence","volume":"18","author":"Walsh","year":"2017","journal-title":"J Am Med Dir Assoc"},{"issue":"948\u2013958","key":"10.1016\/j.rcsop.2022.100190_bb0065","article-title":"Exploring antipsychotic prescribing behaviors for nursing home residents with dementia: a qualitative study","volume":"19","author":"Walsh","year":"2018","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"10.1016\/j.rcsop.2022.100190_bb0070","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/13607863.2021.1922601","article-title":"Improving the appropriateness of psychotropic prescribing for nursing home residents with dementia: an overview of reviews","volume":"26","author":"Wiggin","year":"2021","journal-title":"Aging Ment Health"},{"issue":"2","key":"10.1016\/j.rcsop.2022.100190_bb0075","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/tbm\/ibaa053","article-title":"Identifying behavior change techniques for inclusion in a complex intervention targeting antipsychotic prescribing to nursing home residents with dementia","volume":"11","author":"Walsh","year":"2020","journal-title":"Transl Behav Med"},{"key":"10.1016\/j.rcsop.2022.100190_bb0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Implement Sci"},{"key":"10.1016\/j.rcsop.2022.100190_bb0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.12688\/hrbopenres.13228.1","article-title":"Developing a complex intervention targeting antipsychotic prescribing to nursing home residents with dementia","volume":"4","author":"Walsh","year":"2021","journal-title":"HRB Open Res"},{"key":"10.1016\/j.rcsop.2022.100190_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150205","article-title":"Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework","volume":"11","author":"Eldridge","year":"2016","journal-title":"PLoS One"},{"year":"2017","author":"Creswell","series-title":"Designing and Conducting Mixed Methods Research","key":"10.1016\/j.rcsop.2022.100190_bb0095"},{"year":"2003","author":"Rogers","series-title":"Diffusion of Innovations","key":"10.1016\/j.rcsop.2022.100190_bb0100"},{"issue":"8","key":"10.1016\/j.rcsop.2022.100190_bb0105","article-title":"Local opinion leaders: effects on professional practice and health care outcomes","author":"Flodgren","year":"2011","journal-title":"Cochrane Libr"},{"key":"10.1016\/j.rcsop.2022.100190_bb0110","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM198306163082406","article-title":"Improving drug-therapy decisions through educational outreach: a randomized controlled trial of academically based detailing","volume":"308","author":"Avorn","year":"1983","journal-title":"N Engl J Med"},{"year":"2016","author":"Centre for Effective Practice","series-title":"Use of Antipsychotics in Behavioural and Psychological Symptoms of Dementia (BPSD) Discussion Guide: Long-Term Care (LTC 2nd Edition)","key":"10.1016\/j.rcsop.2022.100190_bb0115"},{"key":"10.1016\/j.rcsop.2022.100190_bb0120","first-page":"17","article-title":"Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline","volume":"64","author":"Bjerre","year":"2018","journal-title":"Can Fam Physician"},{"year":"2022","author":"WHO","series-title":"Collaborating Centre for Drug Statistics Methodology. About the ATC\/DDD System. Vol 20152015","key":"10.1016\/j.rcsop.2022.100190_bb0125"},{"key":"10.1016\/j.rcsop.2022.100190_bb0130","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rcsop.2022.100190_bb0135","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1017\/S1041610214002816","article-title":"The development and testing of the quality use of medications in dementia (QUM-D): a tool for quality prescribing for behavioral and psychological symptoms of dementia (BPSD)","volume":"27","author":"Peisah","year":"2015","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.rcsop.2022.100190_bb0140","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology."},{"key":"10.1016\/j.rcsop.2022.100190_bb0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00019442-200002000-00010","article-title":"The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement","volume":"Vol. 8","author":"Wood","year":"2000","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.rcsop.2022.100190_bb0150","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1369-7625.2009.00589.x","article-title":"Is primary angioplasty an acceptable alternative to thrombolysis? Quantitative and qualitative study of patient and carer satisfaction","volume":"13","author":"Sampson","year":"2010","journal-title":"Health Expect"},{"key":"10.1016\/j.rcsop.2022.100190_bb0155","series-title":"Qualitative Research Practice: A Guide for Social Science Students and Researchers","first-page":"219","article-title":"Carrying out qualitative analysis","author":"Ritchie","year":"2003"},{"year":"2016","author":"QSR International","series-title":"NVivo 11 Qualitative Data Analysis Software for Windows","key":"10.1016\/j.rcsop.2022.100190_bb0160"},{"issue":"1","key":"10.1016\/j.rcsop.2022.100190_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2055-5784-1-1","article-title":"Pilot and feasibility studies come of age!","volume":"1","author":"Lancaster","year":"2015","journal-title":"Pilot Feasibility Stud"},{"year":"2017","author":"StataCorp","series-title":"STATA Software Version 13","key":"10.1016\/j.rcsop.2022.100190_bb0170"},{"year":"2013","author":"Microsoft","series-title":"Excel 2013","key":"10.1016\/j.rcsop.2022.100190_bb0175"},{"key":"10.1016\/j.rcsop.2022.100190_bb0180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1258\/jhsrp.2007.007074","article-title":"The quality of mixed methods studies in health services research","volume":"13","author":"O\u2019Cathain","year":"2008","journal-title":"J Health Serv Res Policy"},{"key":"10.1016\/j.rcsop.2022.100190_bb0185","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jamda.2019.08.027","article-title":"Optimizing Practices, Use, Care and Services\u2013Antipsychotics (OPUS-AP) in long-term care centers in Qu\u00e9bec, Canada: a strategy for best practices","volume":"21","author":"Cossette","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.rcsop.2022.100190_bb0190","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jamda.2021.12.031","article-title":"Optimizing Practices, Use, Care, and Services\u2013Antipsychotics (OPUS-AP) in long-term care centers in Quebec, Canada: a successful scale-up","volume":"23","author":"Cossette","year":"2022","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.rcsop.2022.100190_bb0195","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.sapharm.2021.03.017","article-title":"Implementation conditions leading to the scale-up of an innovation involving the optimal use of antipsychotics in long-term care centers: the Optimizing Practices, Use, Care and Services-Antipsychotics (OPUS-AP) program","volume":"18","author":"Couturier","year":"2022","journal-title":"Res Social Adm Pharm"},{"year":"2021","author":"National Institute for Health Research","series-title":"Guidance on Applying for Feasibility Studies","key":"10.1016\/j.rcsop.2022.100190_bb0215"},{"key":"10.1016\/j.rcsop.2022.100190_bb0220","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/ageing\/afv131","article-title":"Dementia in older people admitted to hospital: a regional multi-hospital observational study of prevalence, associations and case recognition","volume":"44","author":"Timmons","year":"2015","journal-title":"Age Ageing"},{"key":"10.1016\/j.rcsop.2022.100190_bb0225","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12875-017-0639-8","article-title":"\u201cWe\u2019re certainly not in our comfort zone\u201d: a qualitative study of GPs\u2019 dementia-care educational needs","volume":"18","author":"Foley","year":"2017","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.rcsop.2022.100190_bb0230","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13063-017-1915-6","article-title":"Development of a core outcome set for effectiveness trials aimed at optimising prescribing in older adults in care homes","volume":"18","author":"Millar","year":"2017","journal-title":"Trials."},{"key":"10.1016\/j.rcsop.2022.100190_bb0235","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s40814-018-0290-8","article-title":"Exploratory studies to decide whether and how to proceed with full-scale evaluations of public health interventions: a systematic review of guidance","volume":"4","author":"Hallingberg","year":"2018","journal-title":"Pilot Feasibility Stud"},{"key":"10.1016\/j.rcsop.2022.100190_bb0240","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/0038038509103208","article-title":"Implementing, embedding, and integrating practices: an outline of normalization process theory","volume":"43","author":"May","year":"2009","journal-title":"Sociology."},{"key":"10.1016\/j.rcsop.2022.100190_bb0245","article-title":"Developing and evaluating complex interventions: the new medical research council guidance","volume":"337","author":"Craig","year":"2008","journal-title":"BMJ."}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276622000890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276622000890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:28:19Z","timestamp":1757406499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276622000890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":46,"alternative-id":["S2667276622000890"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2022.100190","relation":{},"ISSN":["2667-2766"],"issn-type":[{"type":"print","value":"2667-2766"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationalising Antipsychotic Prescribing in Dementia (RAPID) complex intervention: A mixed-methods feasibility intervention study","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2022.100190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100190"}}